We next focused our analysis on the enriched immune response transcripts and pathways to further examine the effects of disrupting Snail-p53 binding on the immunomodulatory potential of NSCLC cell line, A549. The gene discussed is SNAI1; the disease is non-small cell lung carcinoma.